New Strong Buy Stocks for June 18th
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 18 2025
0mins
Source: NASDAQ.COM
Strong Buy Stocks: Five stocks have been added to the Zacks Rank #1 (Strong Buy) List, including Rockwell Automation, European Wax Center, Carlsberg, Dell Technologies, and DNB Bank, all showing significant increases in earnings estimates over the past 60 days.
Investment Opportunity: These stocks are considered top picks by Zacks experts for potential gains of +100% or more in the coming year, with previous recommendations having achieved substantial returns.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EWCZ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EWCZ
Wall Street analysts forecast EWCZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EWCZ is 5.00 USD with a low forecast of 4.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
1 Buy
1 Hold
1 Sell
Hold
Current: 3.930
Low
4.00
Averages
5.00
High
6.00
Current: 3.930
Low
4.00
Averages
5.00
High
6.00
About EWCZ
European Wax Center, Inc. is a franchisor and operator of out-of-home (OOH) waxing services in the United States. The Company offers guests hygienic waxing services administered by its licensed, EWC-trained estheticians (its wax specialists). Its technology-enabled guest interface simplifies and streamlines the guest experience with automated appointment scheduling and remote check-in capabilities across its network of centers. It provides a comprehensive assortment of body and facial waxing services using its Comfort Wax formulation, which features a blend of natural beeswax combined with other skin-soothing ingredients for the most comfortable waxing experience. It also provides a line of proprietary pre- and post-service products, including ingrown hair serums, exfoliating gels, brow shapers and skin treatments, which ensure the full benefits of the waxing experience are realized by its guests. The Company’s network includes more than 1,000 centers in 44 states.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
European Wax Center (EWCZ) Stock Rises 5.8%, Demonstrating Strong Momentum
- Significant Price Momentum: European Wax Center (EWCZ) has seen a 5.8% price increase over the past four weeks, indicating growing investor interest and enhancing its attractiveness in the market.
- Long-Term Return Potential: The stock has gained 4.6% over the last 12 weeks, reflecting not only its ability to handle short-term price fluctuations but also its potential for long-term investment, making it suitable for investors seeking stable returns.
- High Volatility Characteristics: With a beta of 1.45, EWCZ's stock price moves 45% more than the market, providing a quick profit opportunity for investors with a higher risk tolerance.
- Valuation Advantage: EWCZ's price-to-sales ratio stands at 0.99, meaning investors pay only 99 cents for every dollar of sales, demonstrating that the stock retains good investment value while experiencing rapid growth.
Continue Reading
European Wax Center (EWCZ) Reports 20 Center Closures, Updates 2025 Sales Outlook to $945 Million
- Center Closures: European Wax Center closed 20 centers in fiscal 2025, below the previous forecast of 23 to 28 closures, reflecting progress in strategic development initiatives and adjustments to optimize operational efficiency.
- Sales Outlook Adjustment: The company raised its fiscal 2025 system-wide sales outlook to $945 million to $948 million, slightly above the previous range of $940 million to $950 million, indicating stability in market demand and business resilience.
- Financial Metrics Update: Adjusted EBITDA is now projected at $72 million to $74 million, an increase from the prior estimate of $69 million to $71 million, demonstrating improvements in cost control and profitability.
- Future Outlook: Management will share further updates at the 2026 ICR Conference, emphasizing the company's focus on enhancing marketing and operational capabilities to navigate the evolving macro environment and drive long-term performance growth.
Continue Reading